Venturi Wealth Management LLC Has $2.09 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Venturi Wealth Management LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,463 shares of the company’s stock after selling 70 shares during the period. Venturi Wealth Management LLC’s holdings in HCA Healthcare were worth $2,093,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Nuveen LLC bought a new position in HCA Healthcare in the first quarter worth $569,217,000. Pacer Advisors Inc. lifted its holdings in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after buying an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP acquired a new stake in shares of HCA Healthcare in the first quarter valued at $164,835,000. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HCA shares. Bank of America raised their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. Wells Fargo & Company lifted their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Barclays lifted their price objective on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Finally, Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $410.83.

HCA Healthcare Price Performance

NYSE:HCA opened at $437.46 on Wednesday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The stock has a market capitalization of $102.36 billion, a PE ratio of 18.39, a price-to-earnings-growth ratio of 1.36 and a beta of 1.40. The business’s 50-day simple moving average is $401.26 and its 200-day simple moving average is $374.10.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter in the previous year, the business posted $5.50 EPS. HCA Healthcare’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is presently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.